• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
News Release
News Release

Spinal Muscular Atrophy in Adults - Academy of Neurologic Physical
Spinal Muscular Atrophy in Adults - Academy of Neurologic Physical

... There  are  no  curative  treatments  available  for  SMA  to  date.  In  the  absence  of  pharmaco-­ logical  therapies,  clinical  management  is  focused  on  prevention  and  treatment  of  com-­ plications  due  to  muscle  weakness.  A  multidisciplinary  team  of  providers  are  needed  to ...
GI_2_-_Diarrhea_2015
GI_2_-_Diarrhea_2015

... C. Difficile: Other Considerations • Age greater than 65, severe underlying illnesses, and ongoing antibiotic treatments during C difficile therapy are all risk factors for recurrence • For the first relapse, the choice of antibiotic should be based on severity – Mild symptoms of recurrence in pati ...
9 million doctor visits/year!
9 million doctor visits/year!

... woman who had symptoms of uncomplicated cystitis, no features of pyelonephritis 70% of bladder cultures positive 78% of voided mid-stream cultures positive As few as 10 CFUs of mid-stream cultures of E. coli or Klebsiella pneumoniae– highly correlated with a true bladder infection ( 93% PPV). In con ...
Implant-Prosthetic Treatment in HIV
Implant-Prosthetic Treatment in HIV

... Purpose: Since 1997, the use of highly active antiretroviral therapy (HAART) has significantly improved systemic health and life expectancy of patients who test positive for the human immunodeficiency virus (HIV) in industrialized countries. Therefore, although implant-supported prosthetic rehabilit ...
Polycythemia - joshcorwin.com
Polycythemia - joshcorwin.com

... disturbances, or nonspecific complaints such as weakness, headaches, or dizziness. Other patients are diagnosed after an incidental finding of an elevated hemoglobin and/or hematocrit level on a complete blood count. ...
2004-July/August
2004-July/August

... administration of these agents 1 hour before meals facilitates better patient functioning in activities of daily living (ADL) in patients with Parkinson’s Disease. This may or may not be due to achievement of a more rapid peak concentration. EPLERENONE (INSPRA™) DENIED FORMULARY APPROVAL – Eplerenon ...
G_ESMAT
G_ESMAT

COMMON VARIABLE IMMUNODEFICIENCY
COMMON VARIABLE IMMUNODEFICIENCY

... is not caused by a treatable infection, the joint fluid may be removed by needle aspiration and studied for the presence of bacteria. In some instances, a bacterium called Mycoplasma may be the cause and can be difficult to diagnose. The typical arthritis associated with CVID may involve the larger ...
COMMON - Canadian Immunodeficiencies Patient Organization
COMMON - Canadian Immunodeficiencies Patient Organization

... is not caused by a treatable infection, the joint fluid may be removed by needle aspiration and studied for the presence of bacteria. In some instances, a bacterium called Mycoplasma may be the cause and can be difficult to diagnose. The typical arthritis associated with CVID may involve the larger ...
A 45 Year Old with Sudden Stroke: A Rare and Silent Culprit
A 45 Year Old with Sudden Stroke: A Rare and Silent Culprit

... The most imperative intervention is to address the underlying pathology promoting calciphylaxis. Examples include removing the offending agent; avoiding trauma; correcting calcium and phosphate abnormalities with noncalcium-phosphate binders; and cinacalcet for elevated PTH. Sodium thiosulfate, dose ...
ENDOMETRIOSIS - Dr Nayan Sarkar`s Blog
ENDOMETRIOSIS - Dr Nayan Sarkar`s Blog

... menopause, usually in association with HRT. Laparoscopic ablation of visible endometriotic lesion in infertile women is associated with significantly increased fertility rates. There is no data regarding early intervention ...
HEMORRHOIDS IRC Consultation
HEMORRHOIDS IRC Consultation

... q Grade IV: hemorrhoids chronically prolapse & cannot be  reduced.  They usually contain both internal and external  components and may present with acute thrombosis or  strangulation.  ...
Slide 1
Slide 1

...  Clinical trial evidence for combining TB & HIV treatment - reduces mortality by 56% in co-infected patients with CD4 < 500  IRIS cases and hospitalizations increased by initiation of ART during TB treatment ...
PowerPoint Slides - Research To Practice
PowerPoint Slides - Research To Practice

... • 2006: High-dose IL-2 for metastatic clear cell carcinoma of the kidney  disease progression – Sunitinib • 2012: Nivolumab on a clinical trial – 18 months later developed pneumonitis and received corticosteroids ...
a. general principles and care objectives
a. general principles and care objectives

... with a longer half-life, which results in more predictable and sustained anticoagulation and allows fixed-dose, once-daily subcutaneous administration, does not require laboratory monitoring. A preferred anticoagulant strategy in those at higher risk of bleeding managed with a noninvasive strategy. ...
Supplemental Digital Content
Supplemental Digital Content

... estimated by multivariate Cox regression using sex, age, donor type, year of transplantation, CMV status, dialysis vintage, diabetes mellitus, primary cause of renal failure and episodes of acute rejection as covariates. The Cox regression model was further adjusted for the baseline serum HBV DNA an ...
ASCO 2017: Janssen to Present 19 Abstracts in Prostate Cancer
ASCO 2017: Janssen to Present 19 Abstracts in Prostate Cancer

... the patient experiences unusual stress. Symptoms and signs of AI may be masked by adverse reactions associated with mineralocorticoid excess seen in patients treated with ZYTIGA®. Perform appropriate tests, if ...
Document
Document

Foscavir 24mg/ml Creatinine Clearance (ml/kg/min) CMV Every 8
Foscavir 24mg/ml Creatinine Clearance (ml/kg/min) CMV Every 8

... Interaction with other Medicinal Products and other Forms of Interaction Since Foscavir can impair renal function, additive toxicity may occur when used in combination with other nephrotoxic drugs such as aminoglycoside antibiotics, amphotericin B and cyclosporin A. Moreover, since Foscavir can redu ...
Pulseless Electrical Activity (PEA)
Pulseless Electrical Activity (PEA)

... SMO: Pulseless Electrical Activity (PEA) Overview: Pulseless Electrical Activity (PEA) refers to any semiorganized electrical activity that can be seen on the monitor screen although the patient lacks a palpable pulse. The definition specifically excludes Ventricular Fibrillation (VF), ventricular t ...
CanCer CliniCal trials
CanCer CliniCal trials

... • What does the trial involve? What kind of tests and treatments? • What is likely to happen in my case, with, or without, this new treatment? • What are my other options and their advantages and disadvantages? • How could the trial affect my daily life? • How often will I have to come to ...
Original Phenazopyridine: A drug utilization research in the Costa Rican Social Security
Original Phenazopyridine: A drug utilization research in the Costa Rican Social Security

... this intervention, it is validly associated with causal antibacterial treatment; this therapy jointly showed a strong tendency towards rational use in the first and second level of care. An important aspect of the findings emerged from this work and based on a habit of prescribing, which also exceed ...
PMS Prof 10.2016 - KU School of Social Welfare
PMS Prof 10.2016 - KU School of Social Welfare

... If the medication is stopped during treatment, the symptoms will recur because the problem is still present. ...
;:! Blue Cross of California @
;:! Blue Cross of California @

... drugs limited to prescription use under an NDA can be exempted from that limitation if the FDA determines the prescription requirements to be unnecessary for the protection of public health. My letter specifically petitions the FDA to convert non sedating antihistamines to OTC regulatory status. Cur ...
< 1 ... 378 379 380 381 382 383 384 385 386 ... 462 >

Management of multiple sclerosis



Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.
  • studyres.com © 2026
  • DMCA
  • Privacy
  • Terms
  • Report